In a strategic move to strengthen Himachal Pradesh's fiscal framework, Chief Minister Sukhvinder Singh Sukhu engaged with Union Finance Min...

China has excluded electric vehicles from its strategic industries list for the 2026-2030 five-year plan, a first in over a decade. This mo...

Under the BioE3 Policy, 21 bioenablers will drive advanced biomanufacturing, reduce reliance on imports, generate employment, and position ...

India has launched a network of advanced biomanufacturing hubs to boost its bioeconomy and drive innovation across sectors like health, agr...

In 2024, South India led India's bioeconomy, contributing 45.4% ($75.2 billion), with Maharashtra, Karnataka, and Telangana emerging as key...

Union Minister Jitendra Singh emphasizes the importance of establishing BioE3 Cells in states as interconnected knowledge hubs. These cells...

In 2024, India's biopharma sector marked notable achievements, with approvals of key biosimilars and the launch of advanced CAR-T therapy. ...

Assam Chief Minister Himanta Biswa Sarma has proposed several initiatives to enhance scientific and technological innovation, and local ind...

India's BioE3 policy is set to revolutionize biotech research with AI-powered bio-foundries. These hubs will speed up experiments and valid...

Union Minister Jitendra Singh highlighted that bio-manufacturing is set to revolutionize the global economy, with India poised to lead due ...

The Union Cabinet has approved the Biotechnology for Economy, Environment, and Employment (BioE3) policy. This initiative aims to enhance r...

US President Joe Biden will deliver a speech on the American revolutionary vision of cancer treatment and cure on Monday in Boston. His add...

"India's Bio-Economy is on way to achieve 150-billion-dollar target from the current 70 billion-dollar to contribute effectively to the Pri...

Addressing a webinar titled 'Global Perspective on India's Biotech Potential: Manufacturing Hub & Foreign Investment', Kant said India is w...

The PM highlighted the need for ‘Make in India’ initiatives in medical devices so that people benefit from the fruits of advances in diagno...

Stelis Biopharma, wholly-owned arm of Strides Arcolab, has commenced construction of its Rs 370 crore (USD 60 million) biologics facility a...

India is facing a severe shortage of people with specialised skills for developing new drugs and may try to rope in consultants of local or...